Results 131 to 140 of about 5,770 (197)

Efficacy and Safety of Mometasone Furoate Nasal Spray in Treating Nasal Polyposis: A Systematic Review and Meta-Analysis. [PDF]

Cureus
Mohya OH, Alghamdi AA, Alomar AA, Alharbi AM, Ageeli AM, Alharbi DH, Alotaibi HM, Alghamdi MS, Alkhamis MA, Shawosh MH, Alayidh RS, Binmahfoodh SA, Albariqi SM, Al-Hakami HA, Al-Garni M.   +14 more
europepmc   +1 more source

The efficacy of mometasone furoate for children with asthma: a meta-analysis of randomized controlled trials. [PDF]

Postepy Dermatol Alergol, 2021
Song Y, Pan K, Chen Y, Wang X, Tian J.
europepmc   +1 more source

In vitro and in silico studies of the interaction between glucocorticoid drug mometasone furoate and model lung surfactant monolayer. [PDF]

RSC Adv
Islam MZ, Krajewska M, Prochaska K, Saha SC.   +3 more
europepmc   +1 more source

Population Pharmacokinetic Analysis of Indacaterol/Glycopyrronium/Mometasone Furoate After Administration of Combination Therapies Using the Breezhaler^® Device in Patients with Asthma. [PDF]

Eur J Drug Metab Pharmacokinet, 2021
Bartels C, Jain M, Yu J, Tillmann HC, Vaidya S.   +4 more
europepmc   +1 more source

Lidocaine vs. Mometasone Furoate Around the Pediatric Tracheal Tube Cuff: Hemodynamic Stress Response and Postoperative Airway Complications: A Prospective, Randomized, Controlled Study. [PDF]

Healthcare (Basel)
Ölç AU, Yılmaz M, Saraçoğlu KT, Cıvraz AZT, Saraçoğlu A, Ratajczyk P.   +5 more
europepmc   +1 more source

Pharmacokinetics of indacaterol, glycopyrronium and mometasone furoate administered as an inhaled fixed-dose combination in Japanese and Caucasian healthy subjects. [PDF]

BMC Pulm Med, 2021
Inoue S, Vaidya S, Tillmann HC, Sakita Y, Machineni S, Heudi O, Furihata K.   +6 more
europepmc   +1 more source

Lung function improvements following inhaled indacaterol/glycopyrronium/mometasone furoate are independent of dosing time in asthma patients: a randomised trial. [PDF]

ERJ Open Res, 2021
Beier J, Watz H, Diamant Z, Hohlfeld JM, Singh D, Pinot P, Jones I, Tillmann HC.   +7 more
europepmc   +1 more source

Mometasone furoate inhibits tumor progression and promotes apoptosis through activation of the AMPK/mTOR signaling pathway in osteosarcoma. [PDF]

J Bone Oncol
Li Z, Fei X, Pan Z, Liang Y, Yang Q, Cheng D.   +5 more
europepmc   +1 more source

Discussion of EMA Draft Guideline on Quality and Equivalence of Topical Products Based on Comparison of Approved Mometasone Furoate Drugs. [PDF]

Dermatol Ther (Heidelb)
Eichner A, Mrestani Y, Hukauf M, Wohlrab J.   +3 more
europepmc   +1 more source

Retraction: Designing of SiO₂ mesoporous nanoparticles loaded with mometasone furoate for potential nasal drug delivery: Ex vivo evaluation and determination of pro-inflammatory interferon and interleukin mRNA expression. [PDF]

Front Cell Dev Biol
Frontiers Editorial Office.
europepmc   +1 more source